2018.11.09PDF( 17KB)
Notification of approval for manufacturing and marketing approval of OABLOK®PATCH in Taiwan (Transdermal, Overactive bladder treatment patch)
2018.10.22PDF( 61KB)
Notification of the commencement of the Phase II clinical study of HP-5070 in Japan (a transdermal drug for the treatment of primary local hyperhidrosis)
2018.10.10
FY02/2019 Q2 Results Earnings Release Presentation
2018.09.28PDF( 62KB)
Notification of application for manufacturing and marketing approval of HP-3000 (Transdermal, Parkinson's disease treatment patch) in Japan
2018.07.06
FY02/2019 Q1 Results Earnings Release Presentation